Genetic Clues for Skin Cancer Therapies Lynbrook NY

Scientists have isolated a group of genetic mutations involved in the growth of melanoma, the deadliest form of skin cancer. Their work may lead to therapies with existing drugs that target the same mutations. Led by Yardena Samuels of the National Human Genome Research Institute, the research team from the U.S. National Institutes of Health (NIH) sequenced the protein tyrosine kinase (PTK) gene family in tumor and blood samples from people with metastatic melanoma.

Local Companies

Barry David Goldman
(212) 585-2404
19 E 80Th St
New York, NY
Natalie Dancis Goldberg
(212) 595-5858
150 W End Ave Apt 27L
New York, NY
Kenneth Mattucci
(516) 482-8778
333 E Shore Rd # 102
Manhasset, NY
David Cooper
(516) 365-2300
3111 New Hyde Park Rd
New Hyde Park, NY
Schweiger Dermatology
(646) 626-7810
110 East 55th St.
New York, NY
Kathleen E Davis
(212) 334-1155
568 Broadway # 303
New York, NY
Ronald Shelton
(212) 593-1818
260 E 66Th St
New York, NY
Ingrid Olhoffer
(718) 792-4700
3620 E Tremont Ave
Bronx, NY
Ralph A Massey
(516) 773-4500
233 E Shore Rd
Great Neck, NY
Sebahat Gereme
(718) 240-5855
625 Rockaway Pkwy
Brooklyn, NY
Data Provided by:
  

Provided By:

MONDAY, Aug. 31 (HealthDay News) -- Scientists have isolated a group of genetic mutations involved in the growth of melanoma, the deadliest form of skin cancer. Their work may lead to therapies with existing drugs that target the same mutations.

Led by Yardena Samuels of the National Human Genome Research Institute, the research team from the U.S. National Institutes of Health (NIH) sequenced the protein tyrosine kinase (PTK) gene family in tumor and blood samples from people with metastatic melanoma. Their study is published in the September issue of the journal Nature Genetics.

"We have found what appears to be an Achilles' heel of a sizable share of melanomas," Samuels, an investigator in the cancer genetics branch of the institute's Division of Intramural Research, said in a NIH news release.

The PTK family includes many genes that, when mutated, promote many types of cancer, including brain, gastric and lung malignancies, according to background information provided in the news release. In the new NIH study, one PTK gene that appeared particularly suspicious was the ERBB4 gene. Scientists found ERBB4 mutations in 19 percent of patients' tumors, making it the most frequently mutated PTK gene in melanoma. Additional lab studies found that melanoma cells with the ERBB4 defect were dependent on the mutant gene for their growth.

The researchers also found that two additional PTK genes -- FLT1 and PTK2B -- were mutated in about 10 percent of the tumor samples.

The discoveries could open up new avenues for therapies. For example, the researchers discovered that melanoma cells grew much more slowly when exposed to lapatinib (Tykerb), a chemotherapy drug that inhibits ERBB4. Lapatinib is already in use by some breast cancer patients. The NIH team is planning a clinical trial using lapatinib in patients with metastatic melanoma harboring ERBB4 mutations.

"Though additional work is needed to gain a more complete understanding of these genetic mutations and their roles in cancer biology, our findings open the door to pursuing specific therapies that may prove useful for the treatment of melanoma with ERBB4 mutations," Samuels stated.

More information

The American Cancer Society has more on melanoma.

SOURCE: U.S. National Institutes of Health, news release, Aug. 30, 2009

Copyright © 2009 ScoutNews, LLC. All rights reserved.

Read Article at HealthDay.com

Related Articles
- Risk Factors for Squamous Cell Cancer of the Skin Lynbrook NY
Squamous cell carcinoma of the skin has multiple risk factors, but the greatest risk factor is sun exposure. Sun: For those who have a long history of sun exposure, the risk of SCC is very high. Individuals who have lived in the Southern USA have a greater chance of developing SCC than those who live in the Northern parts of the country. Worldwide, SCC is again more common in the sunny areas.
- Delayed Prostate Cancer Therapy Lynbrook NY
- Risks for Childhood Cancer Survivors Lynbrook NY
- Getting a Botox Cosmetic Injection Lynbrook NY
- Gene Mutation in Dogs Lynbrook NY
- Healing Facial Spider Veins Lynbrook NY
- High Levels of Selenium Decreases Incidence of Skin Cancer. Lynbrook NY
- Filling in Wrinkles with Dermal Fillers Lynbrook NY
- Breast Cancer Treatment Lynbrook NY
- Follow Up After Skin Cancer Lynbrook NY